What Goes Up … US FDA Expects 2016 NME Approval Total To Come Down
After a record-setting 2015 for new drug approvals, there were not enough applications with user fee goals in 2016 to reach that level again.
You may also be interested in...
The latest drug development news and highlights from our US FDA Performance Tracker.
US FDA's complete response letters dropped from 41 in 2016 to 30 in 2017; quality issues as share of total letters continued to climb.
Gottlieb favors making the letters detailing application problems public, but industry still may oppose it; Senate schedules cloture vote for confirmation.